Yeah TLX592 seems OK in that respect though.
Early days but from their proof of concept study recently released;
Initial results demonstrate rapid elimination from blood circulation compared to standard antibodies and hepatic (liver) clearance – both highly desirable characteristics for use with alpha emitting agents.
CU6 - Media and Industry News, page-161
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.42 |
Change
0.350(6.90%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $5.10 | $5.53 | $5.10 | $8.270M | 1.560M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1951 | $5.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.44 | 4280 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |